Related Experiment Videos
Not all chronic urticaria is "idiopathic"!
1St John's Institute of Dermatology, St Thomas' Hospital, London, UK.
Experimental Dermatology
|March 28, 1998
Summary
A subset of chronic "idiopathic" urticaria patients have IgG autoantibodies against the high-affinity IgE receptor (FcεRIα). This discovery aids in understanding chronic urticaria causes and potential treatments.
Area of Science:
- Immunology
- Dermatology
- Allergy Research
Background:
- The etiology of chronic urticaria is often unknown, with physical urticarias having an unidentified cause.
- A significant portion of chronic "idiopathic" urticaria cases remain unexplained.
Purpose of the Study:
- To identify the specific cause of chronic "idiopathic" urticaria in a subset of patients.
- To investigate the role of autoantibodies in the pathogenesis of chronic urticaria.
Main Methods:
- Identified IgG autoantibodies targeting the high-affinity IgE receptor (FcεRIα) in chronic urticaria patients.
- Utilized autologous serum skin testing and evoked histamine release assays.
- Assessed histamine release from normal donor basophils.
Main Results:
- Approximately 30% of chronic "idiopathic" urticaria patients possess IgG autoantibodies against FcεRIα.
- These autoantibodies stimulate mast cell and basophil activation via FcεRI, leading to whealing and angioedema.
- Autoantibody-positive and -negative patients are clinically indistinguishable.
Conclusions:
- IgG autoantibodies against FcεRIα are a significant cause of chronic urticaria in a distinct patient subset.
- Standard antihistamine treatment is effective for both autoantibody-positive and -negative patients.
- Severely affected autoantibody-positive patients may benefit from non-specific immunotherapies like plasma exchange, IVIg, or cyclosporine.